Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

EP300 (E1A binding protein p300)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

‹

OncoGuide™ NCC Oncopanel System

SureSeq™ Pan-Myeloid Panel

oncoReveal™ Core LBx

OncoGuide™ NCC Oncopanel System

SureSeq™ Pan-Myeloid Panel

oncoReveal™ Core LBx

›

EP300 mutation + Chr del(8p)	Chronic Lymphocytic Leukemia	EP300 mutation + Chr del(8p)	Chronic Lymphocytic Leukemia	ibrutinib Resistant: C3 – Early Trials ibrutinib Resistant : C3	ibrutinib Resistant: C3 – Early Trials ibrutinib Resistant : C3
FANCD2 mutation + EP300 mutation	Squamous Cell Carcinoma of Head and Neck	FANCD2 mutation + EP300 mutation	Squamous Cell Carcinoma of Head and Neck	AN2025 Sensitive: C3 – Early Trials AN2025 Sensitive : C3	AN2025 Sensitive: C3 – Early Trials AN2025 Sensitive : C3
PIK3CA mutation + EP300 mutation	Squamous Cell Carcinoma of Head and Neck	PIK3CA mutation + EP300 mutation	Squamous Cell Carcinoma of Head and Neck	AN2025 Sensitive: C3 – Early Trials AN2025 Sensitive : C3	AN2025 Sensitive: C3 – Early Trials AN2025 Sensitive : C3
EP300 mutation	Diffuse Large B Cell Lymphoma	EP300 mutation	Diffuse Large B Cell Lymphoma	Sensitive: C3 – Early Trials Sensitive : C3	Sensitive: C3 – Early Trials Sensitive : C3
EP300 overexpression	Diffuse Large B Cell Lymphoma	EP300 overexpression	Diffuse Large B Cell Lymphoma	Resistant: C3 – Early Trials Resistant : C3	Resistant: C3 – Early Trials Resistant : C3
EP300 mutation	Diffuse Large B Cell Lymphoma	EP300 mutation	Diffuse Large B Cell Lymphoma	YF2 Sensitive: D – Preclinical YF2 Sensitive : D	YF2 Sensitive: D – Preclinical YF2 Sensitive : D